Home Amylgen

Amylgen

In operation
-
Pharmaceutical and Health Product R&D Providers
Basic
Enterprise Profile

Basic Information

Amylgen is a CRO that proposes innovative in vivo models targeting aging, psychiatric disorders, and neurodegenerative diseases for the development of new drugs or nutraceuticals. Amylgen can provide rapid POC for your product as a brain health food supplement and help confirm your product's efficacy through preclinical studies in rodent models.
Amylgen
France
less than 15 people
January 01, 2009
--

Enterprise Profile

Industrial Sector
Health Supplement Manufacturing New Drug Development Drug Trial Clinical Trial Institution
Technology
Biotechnology
Concept
Department of Preventive Healthcare Disease Treatment # Nervous System Diseases
Application Scenarios
Innovative Drugs